Increased Rates of Infectious Diseases in Fibromyalgia Patients: A Population-Based Case-Control Study

Michal Vinker-Shuster1,2, Eli Magen2,3,4, Ilan Green3,5

  • 1Department of Pediatrics, Assuta Ashdod University Medical Center, Ashdod 7747629, Israel.

Biomedicines
|January 8, 2025
PubMed

Insights

Fibromyalgia (FM) patients experience higher rates of infections, including respiratory, gastrointestinal, and genitourinary types, compared to the general population. This highlights a significant increased susceptibility to various infectious diseases in individuals with FM.

Area of Science:

  • Rheumatology
  • Infectious Diseases
  • Epidemiology

Background:

  • Fibromyalgia (FM) is a complex chronic pain condition often associated with various comorbidities.
  • Understanding the infection risk in FM patients is crucial for comprehensive patient care.

Purpose of the Study:

  • To compare the incidence of infectious diseases in fibromyalgia patients versus the general population.
  • To characterize the types and rates of infections in FM patients.

Main Methods:

  • A nationwide population-based case-control study was conducted in Israel from 2002 to 2023.
  • 9,232 FM patients were compared to 46,160 matched controls, analyzing medical records for infectious disease diagnoses (ICD-9 codes).
  • Mean follow-up was 6.7 years, comparing infection rates between groups.

Main Results:

  • FM patients exhibited significantly higher incidence rates for viral, bacterial, fungal, and parasitic diseases.
  • Elevated odds ratios (ORs) were observed in FM patients for respiratory infections (e.g., influenza OR=1.80, pneumonia OR=1.60), gastrointestinal infections (e.g., H. pylori OR=2.05, candidal esophagitis OR=7.88), and genitourinary infections (e.g., UTI OR=1.79, PID OR=3.17).
  • Higher prevalence of skin infections (abscess OR=1.74, cellulitis OR=1.64) and systemic infections like COVID-19 (OR=1.76) and Cytomegalovirus (CMV) (OR=1.85) were also noted.

Conclusions:

  • Fibromyalgia patients demonstrate a significantly increased incidence of infectious diseases compared to the general population.
  • Further research is warranted to elucidate the underlying mechanisms driving this heightened susceptibility.
  • Targeted interventions may be necessary to mitigate infection risks in the FM population.